Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Dynamic regulation of hepatic lipid metabolism by torsinA and its activators
Antonio Hernandez-Ono, Yi Peng Zhao, John W. Murray, Cecilia Östlund, Michael J. Lee, Angsi Shi, William T. Dauer, Howard J. Worman, Henry N. Ginsberg, Ji-Yeon Shin
Antonio Hernandez-Ono, Yi Peng Zhao, John W. Murray, Cecilia Östlund, Michael J. Lee, Angsi Shi, William T. Dauer, Howard J. Worman, Henry N. Ginsberg, Ji-Yeon Shin
View: Text | PDF
Research Article Hepatology Metabolism

Dynamic regulation of hepatic lipid metabolism by torsinA and its activators

  • Text
  • PDF
Abstract

Depletion of torsinA from hepatocytes leads to reduced liver triglyceride secretion and marked hepatic steatosis. TorsinA is an atypical ATPase that lacks intrinsic activity unless it is bound to its activator, lamina-associated polypeptide 1 (LAP1) or luminal domain–like LAP1 (LULL1). We previously demonstrated that depletion of LAP1 from hepatocytes has more modest effects on liver triglyceride secretion and steatosis development than depletion of torsinA. We now show that depletion of LULL1 alone does not significantly decrease triglyceride secretion or cause steatosis. However, simultaneous depletion of both LAP1 and LULL1 leads to defective triglyceride secretion and marked steatosis similar to that observed with depletion of torsinA. Depletion of both LAP1 and torsinA from hepatocytes generated phenotypes similar to those observed with only torsinA depletion, implying that the 2 proteins act in the same pathway in liver lipid metabolism. Our results demonstrate that torsinA and its activators dynamically regulate hepatic lipid metabolism.

Authors

Antonio Hernandez-Ono, Yi Peng Zhao, John W. Murray, Cecilia Östlund, Michael J. Lee, Angsi Shi, William T. Dauer, Howard J. Worman, Henry N. Ginsberg, Ji-Yeon Shin

×

Figure 6

Depletion of LAP1 and LULL1 from hepatocytes leads to decreased liver TG secretion similar to that occurring with torsinA depletion.

Options: View larger image (or click on image) Download as PowerPoint
Depletion of LAP1 and LULL1 from hepatocytes leads to decreased liver TG...
(A) Plasma TG concentration versus time after injection of tyloxapol to block peripheral uptake in LUL-flox and LUL-CKO mice 5 days after injection of adenoviral vectors expressing either control scrambled shRNA (Ad-ctrl) or shRNA that targets LAP1 (Ad-Lap1). Values are mean ± SEM, with each circle, square, or triangle representing the value for an individual mouse (n = 6). (B) TG secretion rates were calculated by changes in plasma concentration between the 30- and 120-minute time points in A. Values are mean ± SEM, with each symbol representing the value from an individual mouse (n = 6). *P < 0.05; **P < 0.01; ****P < 0.0001 by 1-way ANOVA followed by Tukey’s post hoc test. (C) Autoradiogram of SDS-polyacrylamide gel showing 35S-labeled plasma proteins collected 60 minutes after injection of mice with 35S-methionine. Each lane shows protein from an individual mouse (n = 3 per group). Migrations of 35S-labeled apoB100 and apoB48 are indicated. Proteins depleted from the cells are indicated at the bottom of the autoradiogram. (D) Bands corresponding to apoB100 (upper panel) and apoB48 (lower panel) from 2 different gel images obtained from 2 separate experiments were quantified by densitometry and shown as a percentage of the value from the Ad-ctrl–injected LUL-flox mice. Values are mean ± SEM, with each symbol representing the value from an individual mouse (n = 6). *P < 0.05; **P < 0.01; ****P < 0.0001 by 1-way ANCOVA with Tukey’s post hoc test to adjust for the experiment date as a covariate. NS, not significant.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts